More than one intracellular processing bottleneck delays the secretion of coagulation factor VII

Summary

Coagulation factorVII (FVII) is a vitamin K-dependent glycoprotein that undergoes extensive post-translational modification prior to secretion. Secretion of FVII proteins from producer cells is a slow process. To identify bottlenecks for the transport of FVII through the secretory pathway of FVII-producing cells, we analysed the processing of intracellular FVII by pulse-chase of FVII producing CHO cells followed by radioimmuno precipitation, SDS-PAGE, and autoradiography. FVII was coprecipitated with GRP78 and vice versa for at least three hours after synthesis of the labelled FVII, suggesting that nascent FVII is retained in the endoplasmic reticulum (ER). Judged from barium citrate precipitation assay, gamma-carboxylation of the pulse-labelled FVII was a slow process requiring several hours and seemed to be the most important bottleneck in the intracellular processing of FVII. Nevertheless, FVII was not released from the cells immediately after gamma-carboxylation. Gamma-carboxylated FVII accumulated in the cells and migrated as a band with reduced mobility compared to uncarboxylated FVII. This shift in migration was caused by N-glycan processing in the Golgi complex. Thus, the release of FVII from producer cells is delayed by at least two bottlenecks. The major bottleneck appears to be gamma-carboxylation, which determines the rate of transport of FVII out of the ER. Another bottleneck retains FVII in the cells after processing of the N-glycans into complex chains. Cells with an intact gamma-carboxylation machinery appear to posses mechanisms that protect nascent FVII from intracellular degradation and keep FVII in the ER until it is gamma-carboxylated.

Keywords

Factor VII - protein processing - post-translational - gammaarboxylation - glycosylation

• References

• 1 Hedner U. Mechanism of action of factor VIIa in the treatment of coagulopathies. Sem Thromb Hemost 2006; 32 (Suppl. 01) 77-85.
• 2 Pipe SW. Recombinant clotting factors. Thromb Haemost 2008; 99: 840-850.
• 3 Kaufman RJ. Post-translational modifications required for coagulation factor secretion and function. Thromb Haemost 1998; 79: 1068-1079.
• 4 Jorgensen MJ, Cantor AB, Furie BC. et al. Recognition site directing vitamin K-dependent γ-carboxylation resides on the propeptide of factor IX. Cell 1987; 48: 185-191.
• 5 Stanley TB, Wu S-M, Houben RJTJ. et al. Role of the propeptide and γ-glutamic acid domain of factor IX for in vitro carboxylation by the vitamin K-dependent carboxylase. Biochemistry 1998; 37: 13262-13268.
• 6 Stenflo J, Fernlund P, Egan W. et al. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA 1974; 71: 2730-2733.
• 7 Morris DP, Stevens RD, Wright DJ. et al. Processive post-translational modification. J Biol Chem 1995; 270: 30491-30498.
• 8 Thim L, Bjoern S, Christensen M. et al. Amino acid sequence and post-translational modifications of human factor VII_a from plasma and transfected baby hamster kidney cells. Biochemistry 1988; 27: 7785-7793.
• 9 Hagen FS, Gray CL, O’Hara P. et al. Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA 1986; 83: 2412-2416.
• 10 Kornfeld R, Kornfeld S. Asssembly of asparagine-linked oligosaccharides. Ann Rev Biochem 1985; 54: 631-664.
• 11 Nishimura H, Kawabata S-I. Kisiel W, et al. Identification of a discaccharide (Xyl-Glc) and a trisaccharide (XYl₂-Glc) Oglycosidically linked to a serine residue in the first epidermal growth factor-like domain of human factors VII and IX and protein Z and bovine protein Z. J Biol Chem 1989; 264: 20320-20325.
• 12 Bjoern S, Foster DC, Thim L. et al. Human plasma and recombinant factor VII. J Biol Chem 1991; 266: 11051-11057.
• 13 Luo Y, Haltiwanger RS. O-fucosylation of Notch occurs in the endoplasmic reticulum. J Biol Chem 2005; 280: 11289-11294.
• 14 Acar M, Jafar-Nejad H, Takeuchi H. et al. Rumi is a CAP10 domain glycosyltransferase that modifies Notch and is required for Notch signalling. Cell 2008; 132: 247-258.
• 15 Enjolras N, Plantier J-L, Rodriguez M-H. et al. Two novel mutations in EGF-like domains of human factor IX dramatically impair intracellular processing and secretion. J Thromb Haemost 2004; 02: 1143-1154.
• 16 Arbini AA, Mannucci PM, Bauer KA. A Thr359Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule. Blood 1996; 87: 5085-5094.
• 17 Velasco A, Hendricks L, Moremen KW. et al. Cell type-dependent variations in the subcellular distribution of α-mannosidase I and II. J Cell Biol 1993; 122: 39-51.
• 18 Griffiths G, Simmons K. The trans Golgi network: sorting at the exit site of the Golgi complex. Science 1986; 234: 438-443.
• 19 Bolt G, Steenstrup TD, Kristensen C. All post-translational modifications except propeptide cleavage are required for optimal secretion of coagulation factor VII. Thromb Haemost 2007; 98: 988-997.
• 20 Wallin R, Stanton C, Hutson SM. Intracellular maturation of the γ-carboxyglutamic acid (Gla) region in prothrombin coincides with release of the propep-tide. Biochem J 1993; 291: 723-727.
• 21 Peyvandi F, Carew JA, Perry DJ. et al. Abnormal secretion and function of recombinant human factor VII as the result of modification to a calcium binding site caused by a 15-base pair insertion in the F7 gene. Blood 2001; 97: 960-965.
• 22 Bolt G, Kristensen C, Steenstrup TD. Posttranslational N-glycosylation takes place during the normal processing of human coagulation factor VII. Glycobiology 2005; 15: 541-547.
• 23 Berkner KL. Expression of recombinant vitamin K-dependent proteins in mammalian cells: factors IX and VII. Methods Enzymol 1993; 222: 450-476.
• 24 Wu SM, Cheung WF, Frazier D. et al. Cloning and expression of the cDNA for human glutamyl carboxylase. Science 1991; 254: 1634-1636.
• 25 Malhotra OP. Purification and characterization of dicumarol-induced prothrombins. II. Barium oxalate atypical (5-Gla) variant. Thromb Res 1979; 15: 439-448.
• 26 Stafford DW. The vitamin K cycle. J Thromb Hae-most 2005; 03: 1873-1878.
• 27 Cranenberg ECM, Schurgers LJ, Vermeer C. Vitamin K: the coagulation vitamin that became omnipotent. Thromb Haemost 2007; 98: 120-125.
• 28 Tarentino AL, Plummer Jr TH, Maley F. The release of intact oligosaccharides from specific glycoproteins by endo-β-N-acetylglucosaminidase H. J Biol Chem 1974; 249: 818-824.
• 29 Muramatsu T. Endo-β-N-acetylglucosaminidases. CRC Handbook of endoglycosidases and glycoamidases (edsTakahashi N, and Muramatsu T) CRC Press, Boca Raton, Florida. 1992; 13-40.
• 30 Klausen NK, Bayne S, Plam L. Analysis of the site-specific asparagine-linked glycosylation of recombinant human coagulation factor VIIa by glycosidase digestions, liquid chromatography, and mass spectrometry. Mol Biotechnol 1998; 09: 195-204.
• 31 Tulsiani DRP, Hubbard SC, Robbins PW. et al. α-D-Mannosidases of rat liver Golgi membranes. J Biol Chem 1982; 257: 3660-3668.
• 32 Kaufman RJ, Wasley LC, Furie BC. et al. Expression, purification, and characterization of recombinant γ-carboxylated factor IX synthesized in Chinese hamster ovary cells. J Biol Chem 1986; 261: 9622-9628.
• 33 Sinha U, Hancock TE, Nzerem JJ. et al. Effect of gamma carboxylation on prothrombinase inhibitory activity of catalytically inactive factor XA. Thromb Res 1994; 75: 427-436.
• 34 Sun Y-M, Jin D-A, Camire RM. et al. Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X. Blood 2005; 106: 3811-3815.
• 35 Wajih N, Hutson SM, Owen J. et al. Increased production of functional recombinant human clotting factor IX by baby hamster kidney cells engineered to over-expressVKORC1, the vitamin K 2,3-epoxide-reducing enzyme of the vitamin K cycle. J Biol Chem 2005; 280: 31603-31607.
• 36 Lodish HF, Kong N, Snider M. et al. Hepatoma secretory proteins migrate from rough endoplasmic reticulum to Golgi at characteristic rates. Nature 1983; 304: 80-83.
• 37 Souri M, Koseki-Kuno S, Iwata H. et al. A naturally occurring E30Q mutation in the Gla domain of protein Z causes its impaired secretion and subsequent deficiency. Blood 2005; 105: 3149-3154.
• 38 Naito M, Mimuor J, Endo H. et al. Defective sorting to secretory vesicles in trans-Golgi network is partly responsible for protein C deficiency: molecular mechanisms of impaired secretion of abnormal protein C R169W, R352W, and G376D. Circ Res 2003; 92: 865-872.